Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Merz Pharma patents

Patents where

Current Assignee

Name

Merz Pharma

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 9809809 Neurotoxins exhibiting shortened biological activity	Patent 9809809 was granted and assigned to Merz Pharma on November, 2017 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	9809809	November 7, 2017
‌ US Patent 11357821 Recombinant clostridial neurotoxins with increased duration of effect	Patent 11357821 was granted and assigned to Merz Pharma on June, 2022 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	11357821	June 14, 2022
‌ US Patent 9975929 Recombinant clostridial neurotoxins with increased duration of effect	Patent 9975929 was granted and assigned to Merz Pharma on May, 2018 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	9975929	May 22, 2018
‌ US Patent 11331434 Botulinum toxin prefilled syringe system	Patent 11331434 was granted and assigned to Merz Pharma on May, 2022 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	11331434	May 17, 2022
‌ US Patent 9827298 Neurotoxins exhibiting shortened biological activity	Patent 9827298 was granted and assigned to Merz Pharma on November, 2017 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	9827298	November 28, 2017
‌ US Patent 10549042 Botulinum toxin prefilled glass syringe	Patent 10549042 was granted and assigned to Merz Pharma on February, 2020 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	10549042	February 4, 2020
‌ US Patent 10105421 Therapeutic composition with a botulinum neurotoxin	Patent 10105421 was granted and assigned to Merz Pharma on October, 2018 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	10105421	October 23, 2018
‌ US Patent 11324672 Method for preparing hyaluronic acid dermal fillers, dermal fillers obtained thereby and their use	Patent 11324672 was granted and assigned to Merz Pharma on May, 2022 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	11324672	May 10, 2022
‌ US Patent 11529398 Use of botulinum neurotoxin in the treatment of sialorrhea	Patent 11529398 was granted and assigned to Merz Pharma on December, 2022 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	11529398	December 20, 2022
‌ US Patent 7598384 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors	Patent 7598384 was granted and assigned to Merz Pharma on October, 2009 by the United States Patent and Trademark Office.		Merz Pharma	United States Patent and Trademark Office	7598384	October 6, 2009
‌ US Patent 9173944 Formulation suitable for stabilizing proteins, which is free of mammalian excipients	Patent 9173944 was granted and assigned to Merz Pharma on November, 2015 by the United States Patent and Trademark Office.		Merz Pharma	United States Patent and Trademark Office	9173944	November 3, 2015
‌ US Patent 9198856 Formulation for stabilizing proteins, which is free of mammalian excipient	Patent 9198856 was granted and assigned to Merz Pharma on December, 2015 by the United States Patent and Trademark Office.		Merz Pharma	United States Patent and Trademark Office	9198856	December 1, 2015
‌ US Patent 11344573 Treatment of gynoid lipodystrophy		Merz Pharma	Merz Pharma	United States Patent and Trademark Office	11344573	May 31, 2022
‌ US Patent 7947689 Substituted pyrazolo[1,5-a]pyrimidines as metabotropic glutamate receptor modulators	Patent 7947689 was granted and assigned to Merz Pharma on May, 2011 by the United States Patent and Trademark Office.		Merz Pharma	United States Patent and Trademark Office	7947689	May 24, 2011
‌ US Patent D973872 Pushrod	Patent D973872 was granted and assigned to Merz Pharma on December, 2022 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	D973872	December 27, 2022
‌ US Patent 11382960 High frequency application of botulinum toxin therapy	Patent 11382960 was granted and assigned to Merz Pharma on July, 2022 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	11382960	July 12, 2022
‌ US Patent D973871 Pushrod	Patent D973871 was granted and assigned to Merz Pharma on December, 2022 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	D973871	December 27, 2022
‌ US Patent 11078472 Recombinant clostridial neurotoxins with increased duration of effect	Patent 11078472 was granted and assigned to Merz Pharma on August, 2021 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	11078472	August 3, 2021
‌ US Patent 9572871 High frequency application of botulinum toxin therapy	Patent 9572871 was granted and assigned to Merz Pharma on February, 2017 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	9572871	February 21, 2017
‌ US Patent 10335512 Dermal filler based on crosslinked hyaluronic acid and carboxymethyl cellulose lubricant	Patent 10335512 was granted and assigned to Merz Pharma on July, 2019 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	10335512	July 2, 2019
‌ US Patent 10413491 In vivo accelerated degradation of polysaccharide-containing fillers	Patent 10413491 was granted and assigned to Merz Pharma on September, 2019 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	10413491	September 17, 2019
‌ US Patent 9511114 Neurotoxins exhibiting shortened biological activity	Patent 9511114 was granted and assigned to Merz Pharma on December, 2016 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	9511114	December 6, 2016
‌ US Patent 8394857 1-amino-alkylcyclohexane derivatives for the treatment of inflammatory skin diseases	Patent 8394857 was granted and assigned to Merz Pharma on March, 2013 by the United States Patent and Trademark Office.		Merz Pharma	United States Patent and Trademark Office	8394857	March 12, 2013
‌ US Patent 9963502 Antibody that specifically binds partially processed or unprocessed neurotoxin polypeptides	Patent 9963502 was granted and assigned to Merz Pharma on May, 2018 by the United States Patent and Trademark Office.		Merz Pharma	United States Patent and Trademark Office	9963502	May 8, 2018
‌ US Patent 10406290 Botulinum toxin prefilled plastic syringe	Patent 10406290 was granted and assigned to Merz Pharma on September, 2019 by the United States Patent and Trademark Office.	Merz Pharma	Merz Pharma	United States Patent and Trademark Office	10406290	September 10, 2019

Results per page:

83 results

0 selected

83 results

0 selected